Institutions / Victory Capital Management, Inc. / Activity
Activity — Victory Capital Management, Inc.
2,421 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | Add | iHeartMedia, Inc. Common stock | $2.2K | +519 +4.01% | 13,467 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Ardelyx, Inc. Common stock | $2.2K | +440 +1.64% | 27,325 <0.01% of portfolio | low |
| Q1 2026 as of | Add | M2197Q107 Common stock | $2.2K | +163 +1.24% | 13,310 <0.01% of portfolio | low |
| Q2 2026 as of | Add | HGTY Hagerty, Inc. Common Stock | $2.3K | +190 +1.71% | 11,320 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Stellar Bancorp, Inc. Common stock | $2.3K | +58 +0.76% | 7,688 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Lamb Weston Holdings, Inc. Common stock | $2.3K | +53 +0.24% | 22,047 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Jetblue Airways Corporation Common stock | $2.3K | +520 +1.18% | 44,461 <0.01% of portfolio | low |
| Q1 2026 as of | Add | LXRX Lexicon Pharmaceuticals, Inc. Common Stock | $2.3K | +1K +7.02% | 22,679 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Compass Therapeutics, Inc. Common stock | $2.4K | +1K +7.84% | 14,806 <0.01% of portfolio | low |
| Q2 2026 as of | Add | NeoGenomics Inc Common stock | $2.4K | +162 +0.80% | 20,361 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Ltc Properties Inc Common stock | $2.4K | +65 +0.56% | 11,687 <0.01% of portfolio | low |
| Q2 2026 as of | Add | HTZ Hertz Global Holdings, Inc Common Stock | $2.5K | +1K +2.79% | 39,848 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Centuri Holdings, Inc. Common stock | $2.5K | +84 +0.86% | 9,811 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Digital Turbine, Inc. Common stock | $2.5K | +867 +7.69% | 12,135 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Perrigo Company plc Common stock | $2.5K | +241 +1.10% | 22,206 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Atlanta Braves Holdings, Inc. Common stock | $2.5K | +59 +0.90% | 6,595 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Proto Labs Inc Common stock | $2.5K | +31 +0.84% | 3,730 <0.01% of portfolio | low |
| Q2 2026 as of | Add | SVRA Savara Inc Common Stock | $2.6K | +415 +3.48% | 12,329 <0.01% of portfolio | low |
| Q2 2026 as of | Add | 307359885 Common stock | $2.6K | +11K +50.82% | 32,928 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Kodiak AI Inc Common stock | $2.6K | +370 +3.51% | 10,907 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Atlas Energy Solutions Inc. Common stock | $2.6K | +158 +1.25% | 12,799 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Evolv Technologies Holdings Inc Common stock | $2.7K | +447 +2.42% | 18,938 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Digital Turbine, Inc. Common stock | $2.7K | +212 +1.75% | 12,347 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Medical Properties Trust Inc Common stock | $2.8K | +598 +0.76% | 79,691 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Beam Therapeutics Inc. Common stock | $2.8K | +117 +0.38% | 31,099 <0.01% of portfolio | low |
| Q2 2026 as of | Add | G9087Q102 Common stock | $2.8K | +446 +3.37% | 13,681 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Xeris Biopharma Holdings, Inc. Common stock | $2.8K | +491 +2.75% | 18,331 <0.01% of portfolio | low |
| Q1 2026 as of | Add | GSAT Globalstar, Inc. Common Stock | $2.9K | +43 +0.74% | 5,829 <0.01% of portfolio | low |
| Q2 2026 as of | Add | FRHC Freedom Holding Corp. Common Stock | $2.9K | +22 +1.07% | 2,078 <0.01% of portfolio | low |
| Q2 2026 as of | Add | DENTSPLY SIRONA Inc. Common stock | $2.9K | +272 +0.84% | 32,473 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Nextdoor Holdings, Inc. Common stock | $2.9K | +2K +8.24% | 27,201 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Xencor Inc Common stock | $2.9K | +181 +1.67% | 11,012 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Eos Energy Enterprises, Inc. Common stock | $2.9K | +497 +1.31% | 38,531 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Ocugen, Inc. Common stock | $2.9K | +2K +5.25% | 38,475 <0.01% of portfolio | low |
| Q1 2026 as of | Add | LCTX Lineage Cell Therapeutics, Inc. Common Stock | $2.9K | +2K +7.43% | 26,921 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Lionsgate Studios Corp. Common stock | $3.0K | +196 +0.87% | 22,781 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Happen, Inc. Common stock | $3.0K | +146 +1.15% | 12,889 <0.01% of portfolio | low |
| Q1 2026 as of | Add | LCID Lucid Group, Inc. Common Stock | $3.0K | +320 +2.14% | 15,297 <0.01% of portfolio | low |
| Q2 2026 as of | Add | CTS Corp Common stock | $3.1K | +47 +1.07% | 4,458 <0.01% of portfolio | low |
| Q1 2026 as of | Add | Fastly, Inc. Common stock | $3.1K | +106 +0.67% | 15,857 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Teladoc Health, Inc. Common stock | $3.1K | +365 +1.83% | 20,341 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Leggett & Platt Inc Common stock | $3.1K | +266 +1.25% | 21,475 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Tetra Technologies Inc Common stock | $3.1K | +275 +1.91% | 14,687 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Zymeworks Inc. Common stock | $3.1K | +120 +0.28% | 42,524 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Shake Shack Inc. Common stock | $3.1K | +56 +0.90% | 6,280 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Live Oak Bancshares, Inc. Common stock | $3.1K | +77 +0.18% | 43,665 <0.01% of portfolio | low |
| Q1 2026 as of | Add | 115637100 Common stock | $3.3K | +123 +1.07% | 11,607 <0.01% of portfolio | low |
| Q1 2026 as of | Add | TheRealReal, Inc. Common stock | $3.3K | +363 +3.06% | 12,223 <0.01% of portfolio | low |
| Q1 2026 as of | Add | National Health Investors Inc Common stock | $3.4K | +42 +0.22% | 18,766 <0.01% of portfolio | low |
| Q2 2026 as of | Add | Urban Edge Properties Common stock | $3.4K | +149 +0.21% | 71,932 <0.01% of portfolio | low |